T. Rowe Price Associates’s Pulse Biosciences PLSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $157K | Buy |
+10,398
| New | +$157K | ﹤0.01% | 2792 |
|
|
2024
Q3 | – | Sell |
-10,787
| Closed | -$121K | – | 3017 |
|
|
2024
Q2 | $121K | Buy |
10,787
+778
| +8% | +$8.73K | ﹤0.01% | 2721 |
|
|
2024
Q1 | $88K | Buy |
+10,009
| New | +$88K | ﹤0.01% | 2803 |
|
|
2022
Q3 | – | Sell |
-17,600
| Closed | -$27K | – | 3021 |
|
|
2022
Q2 | $27K | Buy |
17,600
+2,955
| +20% | +$4.53K | ﹤0.01% | 2910 |
|
|
2022
Q1 | $71K | Buy |
14,645
+2,000
| +16% | +$9.7K | ﹤0.01% | 2883 |
|
|
2021
Q4 | $187K | Buy |
12,645
+2,200
| +21% | +$32.5K | ﹤0.01% | 2772 |
|
|
2021
Q3 | $226K | Sell |
10,445
-2,000
| -16% | -$43.3K | ﹤0.01% | 2673 |
|
|
2021
Q2 | $204K | Sell |
12,445
-2,035
| -14% | -$33.4K | ﹤0.01% | 2718 |
|
|
2021
Q1 | $343K | Sell |
14,480
-3,507
| -19% | -$83.1K | ﹤0.01% | 2515 |
|
|
2020
Q4 | $429K | Sell |
17,987
-7,300
| -29% | -$174K | ﹤0.01% | 2305 |
|
|
2020
Q3 | $298K | Buy |
25,287
+10,300
| +69% | +$121K | ﹤0.01% | 2286 |
|
|
2020
Q2 | $157K | Buy |
14,987
+478
| +3% | +$5.01K | ﹤0.01% | 2382 |
|
|
2020
Q1 | $104K | Hold |
14,509
| – | – | ﹤0.01% | 2408 |
|
|
2019
Q4 | $195K | Buy |
14,509
+446
| +3% | +$5.99K | ﹤0.01% | 2400 |
|
|
2019
Q3 | $217K | Buy |
14,063
+88
| +0.6% | +$1.36K | ﹤0.01% | 2364 |
|
|
2019
Q2 | $184K | Buy |
13,975
+32
| +0.2% | +$421 | ﹤0.01% | 2412 |
|
|
2019
Q1 | $245K | Buy |
13,943
+400
| +3% | +$7.03K | ﹤0.01% | 2350 |
|
|
2018
Q4 | $155K | Buy |
13,543
+221
| +2% | +$2.53K | ﹤0.01% | 2434 |
|
|
2018
Q3 | $189K | Buy |
13,322
+178
| +1% | +$2.53K | ﹤0.01% | 2455 |
|
|
2018
Q2 | $199K | Buy |
+13,144
| New | +$199K | ﹤0.01% | 2452 |
|